Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.45 USD | -2.89% | -2.68% | -10.33% |
Financials (USD)
Sales 2024 * | 99.02M | Sales 2025 * | 181M | Capitalization | 459M |
---|---|---|---|---|---|
Net income 2024 * | -126M | Net income 2025 * | -62M | EV / Sales 2024 * | 4.07 x |
Net cash position 2024 * | 55.62M | Net cash position 2025 * | 277M | EV / Sales 2025 * | 1 x |
P/E ratio 2024 * |
-3.74
x | P/E ratio 2025 * |
-8.05
x | Employees | 200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.53% |
Latest transcript on UroGen Pharma Ltd.
1 day | -2.89% | ||
1 week | -2.68% | ||
Current month | -2.68% | ||
1 month | -1.10% | ||
3 months | -16.04% | ||
6 months | +15.65% | ||
Current year | -10.33% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 19-01-02 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 21-07-31 |
Jason Smith
CMP | Compliance Officer | 52 | 20-09-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 12-09-30 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 17-09-30 |
Fred Cohen
BRD | Director/Board Member | 67 | 17-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 13.45 | -2.89% | 424,250 |
24-05-06 | 13.85 | -3.15% | 397,988 |
24-05-03 | 14.3 | +0.28% | 164,415 |
24-05-02 | 14.26 | -0.97% | 157,609 |
24-05-01 | 14.4 | +4.20% | 179,883 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.33% | 459M | |
+10.44% | 107B | |
+0.82% | 106B | |
+7.37% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- URGN Stock